1. Home
  2. BCYC vs EQBK Comparison

BCYC vs EQBK Comparison

Compare BCYC & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • EQBK
  • Stock Information
  • Founded
  • BCYC 2009
  • EQBK 2002
  • Country
  • BCYC United Kingdom
  • EQBK United States
  • Employees
  • BCYC N/A
  • EQBK N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • EQBK Major Banks
  • Sector
  • BCYC Health Care
  • EQBK Finance
  • Exchange
  • BCYC Nasdaq
  • EQBK Nasdaq
  • Market Cap
  • BCYC 566.5M
  • EQBK 696.9M
  • IPO Year
  • BCYC 2019
  • EQBK 2015
  • Fundamental
  • Price
  • BCYC $7.03
  • EQBK $41.92
  • Analyst Decision
  • BCYC Buy
  • EQBK Buy
  • Analyst Count
  • BCYC 10
  • EQBK 6
  • Target Price
  • BCYC $25.00
  • EQBK $44.40
  • AVG Volume (30 Days)
  • BCYC 272.6K
  • EQBK 74.1K
  • Earning Date
  • BCYC 08-05-2025
  • EQBK 07-14-2025
  • Dividend Yield
  • BCYC N/A
  • EQBK 1.47%
  • EPS Growth
  • BCYC N/A
  • EQBK 543.37
  • EPS
  • BCYC N/A
  • EQBK 3.93
  • Revenue
  • BCYC $25,722,000.00
  • EQBK $224,743,000.00
  • Revenue This Year
  • BCYC $7.35
  • EQBK $20.75
  • Revenue Next Year
  • BCYC N/A
  • EQBK $10.37
  • P/E Ratio
  • BCYC N/A
  • EQBK $10.37
  • Revenue Growth
  • BCYC N/A
  • EQBK 56.39
  • 52 Week Low
  • BCYC $6.10
  • EQBK $32.95
  • 52 Week High
  • BCYC $28.67
  • EQBK $50.85
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 32.48
  • EQBK 55.89
  • Support Level
  • BCYC $7.03
  • EQBK $39.20
  • Resistance Level
  • BCYC $7.59
  • EQBK $41.45
  • Average True Range (ATR)
  • BCYC 0.43
  • EQBK 0.87
  • MACD
  • BCYC -0.11
  • EQBK 0.17
  • Stochastic Oscillator
  • BCYC 0.81
  • EQBK 68.81

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About EQBK Equity Bancshares Inc.

Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.

Share on Social Networks: